Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus

Figure 1 Flowchart for patient selection. HCC: Hepatocellular carcinoma; PVTT: Portal vein tumor thrombosis; TIPS: Transjugular intrahepatic portosystemic shunt; CTP: Child-Turcotte-Pugh.

Figure 2 Survival of the two groups. A: Overall survival curves of transjugular intrahepatic portosystemic shunt group and standard treatment group; B: Survival rate with 160 days as the time dividing point. TIPS: Transjugular intrahepatic portosystemic shunt; HR: Hazard ratio; CI: Confidence interval.

Figure 3 Overall survival of patients from transjugular intrahepatic portosystemic shunt group and standard treatment group, with Cheng’s Classification of portal vein tumor thrombus, total bilirubin and Child-Pugh class as subgroups. PVTT: Portal vein tumor thrombosis; TIPS: Transjugular intrahepatic portosystemic shunt; TBIL: Total bilirubin.